Results 161 to 170 of about 1,829,061 (296)

Regulation of Synthetic Biology: Developments Under the Convention on Biological Diversity and Its Protocols. [PDF]

Front Bioeng Biotechnol, 2020
Keiper F, Atanassova A.
europepmc   +1 more source

Convention on Biological Diversity [PDF]

, 2017
Cropper, Angela
core   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source

Biological Diversity and Parasitological Peculiarities of Myxosporea (Cnidaria, Myxozoa) Infecting Merluccius Merluccius (Linnaeus, 1758) in the Sea of Marmara. [PDF]

Acta Parasitol
Yadak D, Gürkanli CT, Okkay S, Çİftçİ Y, Özer A.   +4 more
europepmc   +1 more source

Data on Indicators used in Southeast Asian nations' 4th and 5th National Reports to the Convention on Biological Diversity. [PDF]

Data Brief, 2020
Han X, Young BE, Gill MJ, Hamilton H, Vergara SG.   +4 more
europepmc   +1 more source

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

Molecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis, Jack V. Mills, Wojciech Niedzwiedz, Valentine M. Macaulay   +3 more
wiley   +1 more source

Exploring Metrics of Biological Diversity to Better Predict and Respond to Emerging Diseases. [PDF]

Integr Comp Biol
Swei A, Broughton H, Crews A, Lilly M, Shaw G, Summers S.   +5 more
europepmc   +1 more source

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

Molecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober, Leire Moreno‐Cugnon, Laura Martínez‐Pérez, Amaia Ercilla, Amaia Zabala‐Letona, Adrián Vicente‐Barrueco, Maider Fagoaga‐Eugui, Saioa Garcia‐Longarte, Blanca Calle‐Ciborro, Encarnación Pérez‐Andrés, Onintza Carlevaris, Sara Pozo, Isabel Mendizabal, Ugo Mayor, Arkaitz Carracedo, Violaine Sée, Edurne Berra   +16 more
wiley   +1 more source

Proteomic analysis uncovers biological diversity in molecularly defined endometrial carcinomas. [PDF]

Neoplasia
Cochrane DR, Negri GL, Huvila J, Kalantari F, Farnell DA, Mohammad N, Thompson E, Yang W, Lum A, Spencer SE, Riley R, Jamieson A, Leung S, Chiu D, Chow C, Lim JLP, Köbel M, Kommoss S, Kommoss F, Gilks B, Hoang L, Huntsman DG, Morin GB, McAlpine JN.   +23 more
europepmc   +1 more source

Ethics, Justice and the Convention on Biological Diversity [PDF]

, 2010
Pisupati, Balakrishna, Schroeder, Doris
core